Your browser doesn't support javascript.
loading
Improving the effectiveness of pharmacist-assisted tobacco cessation: a study of participant- and pharmacy-specific differences in quit rates.
Shen, Xian; Bachyrycz, Amy; Anderson, Joe R; Tinker, Dale; Raisch, Dennis W.
Afiliação
  • Shen X; University of Maryland Baltimore School of Pharmacy, Baltimore, MD, USA.
  • Bachyrycz A; University of New Mexico College of Pharmacy, Albuquerque, NM, USA Walgreens, Albuquerque, NM, USA.
  • Anderson JR; University of New Mexico College of Pharmacy, Albuquerque, NM, USA.
  • Tinker D; New Mexico Pharmaceutical Care Foundation, Albuquerque, NM, USA New Mexico Pharmacists Association, Albuquerque, NM, USA.
  • Raisch DW; University of New Mexico College of Pharmacy, Albuquerque, NM, USA draisch@salud.unm.edu.
Ann Pharmacother ; 49(3): 303-10, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25527101
ABSTRACT

BACKGROUND:

The New Mexico Pharmaceutical Care Foundation provided a pharmacist-assisted tobacco cessation program from 2004 to 2010. In evaluating the program, discrepant 6-month quit rates were observed between pharmacies.

OBJECTIVE:

To identify participant- and pharmacy-specific factors associated with improved quit rates.

METHODS:

To supplement data regarding participant characteristics and quit rates, semistructured interviews of 7 participating pharmacists were conducted. Multivariate logistic regression quantified associations between successful abstinence at 6 months and participant characteristics and pharmacy-specific factors.

RESULTS:

Quit rates by pharmacy ranged from 1.1% to 59.4% (mean = 19.1%). There were 1235 participants enrolled at 7 pharmacies, and because of missing participant data, 883 were included in the quantitative analysis. Three pharmacy-specific characteristics distinguished 6-month success rates number and duration of follow-ups and format of counseling sessions. Participants followed up at least 3 times were more likely to quit at 6 months than those contacted once or twice (odds ratio [OR] =4.9; 95% CI = 1.6-15.0). Compared with follow-ups of <15 minutes, longer durations of follow-ups were associated with higher success rates 15 to 30 minutes, OR = 7.2, 95% CI = 3.7-14.3); >30 minutes, OR = 10.0, 95% CI = 3.5-28.9. Participants who attended group sessions were more likely to quit at 6 months than those who attended individual sessions OR = 8.2; 95% CI = 2.8-23.9. Most pharmacists (88%) noted that participants' high or low commitment to quit was associated with success or failure, respectively. Several pharmacists (43%) noted difficulties with follow-up associated with participants' relapse. Time constraints were an obstacle noted by 70% of pharmacists.

CONCLUSIONS:

Pharmacy-specific factors, including counseling format and program intensity, affected success.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmácias / Farmacêuticos / Abandono do Hábito de Fumar Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmácias / Farmacêuticos / Abandono do Hábito de Fumar Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2015 Tipo de documento: Article